AT267197T
Epothilone d, production process, and its use as cytostatic as well as phytosanitary agent
Abstract
The invention relates to epothilone, wherein epothilone of THE relates to compounds of formula (I) R= (hydrogen) and D epothilone R= (meth) and epothilone E of formula (i) R= (hydrogen) and A epothilone R= (meth). The invention further relates to a preparation method, and device further comprises a preparation and application of therapeutic agent, and therapeutic agent in cytostatic agent.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
69 members in 25 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 19647580 | Germany | A | |
| 19707506 | Germany | A | |
| 9706442 | European Patent Office (EPO) | W |
Members69
| Document | Office | Kind | |
|---|---|---|---|
| CA2269118A1 | Canada | A1 | |
| WO9822461A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU5483798A | Australia | A | |
| NO992338D0 | Norway | D0 | |
| NO992338L | Norway | L | |
| ZA9710384B | South Africa | B | |
| CZ175099A3 | Czechia | A3 | |
| EP0941227A1 | European Patent Office (EPO) | A1 | |
| PL333435A1 | Poland | A1 | |
| CN1237970A | China | A | |
| BR9713363A | Brazil | A | |
| IL129558D0 | Israel | D0 | |
| HU0000497A2 | Hungary | A2 | |
| HUP0000497A2 | Hungary | A2 | |
| HK1022314A1 | Hong Kong, China | A1 | |
| KR20000053308A | Republic of Korea | A | |
| TW408119B | Taiwan Province of China | B | |
| NZ335383A | New Zealand | A | |
| JP2001504474A | Japan | A | |
| HU0000497A3 | Hungary | A3 | |
| HUP0000497A3 | Hungary | A3 | |
| IL129558A | Israel | A | |
| AU753546B2 | Australia | B2 | |
| RU2198173C2 | Russian Federation | C2 | |
| EP1367057A1 | European Patent Office (EPO) | A1 | |
| EP0941227B1 | European Patent Office (EPO) | B1 | |
| AT267197TThis record | Austria | T | |
| ATE267197T1 | Austria | T1 | |
| DE59711647D1 | Germany | D1 | |
| DK0941227T3 | Denmark | T3 | |
| PT941227E | Portugal | E | |
| ES2221692T3 | Spain | T3 | |
| CN1196698C | China | C | |
| US2005090535A1 | United States of America | A1 | |
| EP0941227B9 | European Patent Office (EPO) | B9 | |
| ES2221692T4 | Spain | T4 | |
| NO319984B1 | Norway | B1 | |
| CN1680370A | China | A | |
| KR100538095B1 | Republic of Korea | B1 | |
| CZ296164B6 | Czechia | B6 | |
| US7067544B2 | United States of America | B2 | |
| CY2542B1 | Cyprus | B1 | |
| HK1083832A1 | Hong Kong, China | A1 | |
| US2006264482A1 | United States of America | A1 | |
| PL193229B1 | Poland | B1 | |
| CN100344627C | China | C | |
| DK0941227T4 | Denmark | T4 | |
| EP1367057B1 | European Patent Office (EPO) | B1 | |
| AT408612T | Austria | T | |
| ATE408612T1 | Austria | T1 | |
| DE59712968D1 | Germany | D1 | |
| US2008293784A1 | United States of America | A1 | |
| PT1367057E | Portugal | E | |
| DK1367057T3 | Denmark | T3 | |
| ES2312695T3 | Spain | T3 | |
| JP4274583B2 | Japan | B2 | |
| US2009247592A1 | United States of America | A1 | |
| DK0941227T5 | Denmark | T5 | |
| EP0941227B2 | European Patent Office (EPO) | B2 | |
| US2009270466A1 | United States of America | A1 | |
| ES2221692T5 | Spain | T5 | |
| US7759375B2 | United States of America | B2 | |
| US7846952B2 | United States of America | B2 | |
| BR9713363B1 | Brazil | B1 | |
| US2011136185A1 | United States of America | A1 | |
| US8076490B2 | United States of America | B2 | |
| CA2269118C | Canada | C | |
| CZ303422B6 | Czechia | B6 | |
| HU229833B1 | Hungary | B1 |
Numbers
- Application
- 97951233
Titles2
- German
- EPOTHILON D, DESSEN HERSTELLUNG UND DESSEN VERWENDUNG ALS CYTOSTATISCHES MITTEL BZW. ALS PFLANZENSCHUTZMITTEL
- English
- EPOTHILON D, THE PRODUCTION THEREOF AND ITS USE AS CYTOSTATIC AGENT BZW. AS A PLANT PROTECTION AGENT
Classification
- CPC, 11
- C07D417/06
- A01N43/78
- A01N43/90
- A61P35/00
- A01N63/02
- A61P35/04
- C07D493/04
- A61P43/00
- C12P17/167
- A01N63/20
- C12P17/181
- IPC, 13
- A01N43 78
- A01N43 90
- A01N63 02
- A61K31 425
- A61K31 427
- A61P35 00
- C07D417 06
- C07D493 04
- C12P1 04
- C12P17 08
- C12P17 16
- C12P17 18
- C12R1 01